Effect of a second-generation α2δ ligand (pregabalin) on visceral sensation in hypersensitive patients with irritable bowel syndrome

Houghton, I. A.; Fell, C.; Whorwell, P. J.; Jones, I.; Sudworth, D. P.; Gale, J. D.
September 2007
Gut;Sep2007, Vol. 56 Issue 9, p1218
Academic Journal
Background: Visceral hypersensitivity is an important pathophysiological factor in irritable bowel syndrome (IBS). Pre-clinical studies suggest that the α2δ ligand pregabalin reduces both visceral allodynia and hyperalgesia, but is inactive on basal sensitivity. Aim: To assess the effect of pregabalin on the perception of rectal distension in hypersensitive IBS patients. Methods: Twenty-six patients with Rome-II-defined IBS (aged 18–46 years, 7 male) were included in a randomized, double-blind, placebo-controlled, parallel-group study in which they received either 3 weeks oral pregabalin (titrated: 50 mg tid days 1–3, 100 mg tid days 4–7, 150 mg tid days 8–11 ; fixed 200 mg tid days 12–21 ±4) or placebo control. Rectal sensitivity was assessed using a barostat technique, in which sensory thresholds were determined using the ascending method of limits, followed by tracking both before and after treatment. Only patients with a pain threshold of ⩽28 mmHg were included in the study. Results: Pregabalin significantly increased the sensory thresholds from baseline for first sensation (p = 0.045), desire to defecate (p = 0.008) and pain (p = 0.048) compared with placebo control. In addition, pregabalin significantly increased rectal compliance (p<0.0001), although this appeared to be unrelated to the changes in sensitivity. Despite the occurrence of mild dizziness and somnolence, pregabalin was generally well tolerated. Conclusions: Pregabalin increased distension sensory thresholds to normal levels in IBS patients with rectal hypersensitivity. A concomitant increase in rectal compliance appeared to be unrelated to the reduction in sensitivity. These data suggest that α2δ ligands are worthy of further investigation in the treatment of visceral pain disorders, including IBS.


Related Articles

  • Reclaiming the placebo effect. Godlee, Fiona // BMJ: British Medical Journal (International Edition);5/3/2008, Vol. 336 Issue 7651, p966 

    The article discusses several reports published within the issue including one on placebos by Rudiger Pittroff and Ian Rubenstein, and another on irritable bowel disease by a group of authors.

  • SYNBIOTICS IN IRRITABLE BOWEL SYNDROME: A DOUBLE BLIND PROSPECTIVE RANDOMISED CONTROLLED TRIAL. Barker, P.; McNaught, C.E.; Anderson, A.D.G.; Mitchell, C.J.; MacFie, J. // Gut;Apr2003 Supplement 1, Vol. 52, pA11 

    Introduction: Alterations in resident Gl microflora have been implicated in the aetiology of irritable bowel syndrome (lBS) and this provides a theoretical rationale for the use of probiotics in these patients. The aim of this study was to investigate the effects of synbiotics (pre- and...

  • Non-Celiac Wheat Sensitivity Diagnosed by Double-Blind Placebo-Controlled Challenge: Exploring a New Clinical Entity. Carroccio, Antonio; Mansueto, Pasquale; Iacono, Giuseppe; Soresi, Maurizio; D'Alcamo, Alberto; Cavataio, Francesca; Brusca, Ignazio; Florena, Ada M; Ambrosiano, Giuseppe; Seidita, Aurelio; Pirrone, Giuseppe; Rini, Giovanni Battista // American Journal of Gastroenterology;Dec2012, Vol. 107 Issue 12, p1898 

    OBJECTIVES:Non-celiac wheat sensitivity (WS) is considered a new clinical entity. An increasing percentage of the general population avoids gluten ingestion. However, the real existence of this condition is debated and specific markers are lacking. Our aim was thus to demonstrate the existence...

  • Sensitivity Disturbances in Patients with Irritable Bowel Syndrome and Fibromyalgia. Caldarella, Maria P.; Giamberardino, Maria A.; Sacco, Flora; Affaitati, Giannapia; Milano, Angelo; Lerza, Rosanna; Balatsinou, Crysanthi; Laterza, Francesco; Pierdomenico, Sante D.; Cuccurullo, Franco; Neri, Matteo // American Journal of Gastroenterology;Dec2006, Vol. 101 Issue 12, p2782 

    BACKGROUND: Although visceral hypersensitivity is a common feature among patients with irritable bowel syndrome (IBS), studies on somatic sensitivity have given controversial results. AIM: To assess visceral sensitivity in response to isotonic rectal distensions and somatic sensitivity at...

  • Visceral pain originating from the upper urinary tract. Pedersen, Katja Venborg; Drewes, Asbj�rn Mohr; Frimodt-M�ller, Poul Christian; Osther, Palle J�rn Sloth // Urological Research;Oct2010, Vol. 38 Issue 5, p345 

    Pain originating from the upper urinary tract is a common problem and stone colic is one of the most intense pain conditions that can be experienced in the clinic. The pain is difficult to alleviate and often leads to medical attention. In humans, pain mechanisms of the upper urinary tract pain...

  • Lack of Efficacy of Saccharomyces Boulardii in Diarrhea Predominant Irritable Bowel Syndrome -- a Randomized Double--Blind, Placebo Controlled Clinical Trial. Kabir, Md. Anwarul; Ripa, Farhana Alam; Hasan, Mahmud // European Journal of Scientific Research;Dec2009, Vol. 38 Issue 1, p104 

    Irritable Bowel Syndrome (IBS) is a common disorder in Bangladesh. Several studies with probiotics have shown promising results in the treatment of IBS. One of the probiotics used was Saccharomyces boulardii. This is a randomized double blind placebo controlled clinical trial of S. boulardii in...

  • Psyllium Therapy in the Irritable Bowel Syndrome. Longstreth, George F.; Fox, David D.; Youkeles, Lee; Forsythe, Alan B.; Wolochow, Donald A. // Annals of Internal Medicine;Jul81, Vol. 95 Issue 1, p53 

    Presents a study that conducted a randomized, double-blind trial of therapy with a psyllium preparation in patients with painful irritable bowel syndrome. Comparison of diary data during baseline and treatment periods for patients on psyllium and those on placebo; Influence of personality...

  • Would you knowingly take a placebo if it works? Hamzelou, Jessica // New Scientist;1/8/2011, Vol. 209 Issue 2794, p01 

    The article focuses on research into the effect placebos have on people when they know they are taking a placebo. It states that researcher Ted Kaptchuk and colleagues at Harvard Medical School, Massachusetts tested the effect of placebos and no treatment in 80 people suffering irritable bowel...

  • Cholecystokinin enhances visceral pain-related affective memory via vagal afferent pathway in rats.  // Molecular Brain;2012, Vol. 5 Issue 1, p19 

    The article presents a study which measures the learned behavior reflecting the affective component of visceral pain through vagal afferent pathway in rats. It demonstrate that perigenual anterior cingulate cortex (pACC) activation is important in memory processing in long-term visceral...


Read the Article


Sign out of this library

Other Topics